Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
Геномномасштабный скрининг нокаутов CRISPR-Cas9 в человеческих клетках
2013-12-12
SCID: 54.1/py57sfhh
Discuss with AI
GeCKO libraryessential genes in cancer and pluripotent stem cellsgenome-scale CRISPR-Cas9 knockoutlentiviral deliveryvemurafenib resistance
Figures from the paper
Abstract (AI)
The simplicity of programming the CRISPR (clustered regularly interspaced short palindromic repeats)-associated nuclease Cas9 to modify specific genomic loci suggests a new way to interrogate gene function on a genome-wide scale. We show that lentiviral delivery of a genome-scale CRISPR-Cas9 knockout (GeCKO) library targeting 18,080 genes with 64,751 unique guide sequences enables both negative and positive selection screening in human cells. First, we used the GeCKO library to identify genes essential for cell viability in cancer and pluripotent stem cells. Next, in a melanoma model, we screened for genes whose loss is involved in resistance to vemurafenib, a therapeutic RAF inhibitor. Our highest-ranking candidates include previously validated genes NF1 and MED12, as well as novel hits NF2, CUL3, TADA2B, and TADA1. We observe a high level of consistency between independent guide RNAs targeting the same gene and a high rate of hit confirmation, demonstrating the promise of genome-scale screening with Cas9.
Key Findings
1
GeCKO screening identified genes essential for cell viability in both cancer cells and pluripotent stem cells.
2
In a melanoma model screened for vemurafenib resistance, top candidate resistance genes included known NF1 and MED12 and novel hits NF2, CUL3, TADA2B, and TADA1.
3
Independent guide RNAs targeting the same gene showed high consistency, and there was a high rate of hit confirmation, supporting robustness of genome-scale Cas9 screening.
4
Lentiviral delivery of a genome-scale CRISPR-Cas9 knockout (GeCKO) library targeting 18,080 genes with 64,751 unique guide sequences enables negative and positive selection screens in human cells.
Research Object
Lentiviral-delivered genome-scale CRISPR-Cas9 knockout (GeCKO) library applied to human cells
Research Subject
Identification of gene functions via loss-of-function screening across ~18,080 genes (64,751 guides) to detect genes essential for viability and mediating drug resistance (vemurafenib) in human cancer and pluripotent stem cells
Publication Details
Publication Date
2013-12-12
Journal
Publisher
ISSN
Cited by
5237
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
Cited by7
The new frontier of genome engineering with CRISPR-Cas92014
The CRISPR tool kit for genome editing and beyond2018
Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery2018
Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR2015
A guide for the diagnosis of rare and undiagnosed disease: beyond the exome2022
Affecting HEK293 Cell Growth and Production Performance by Modifying the Expression of Specific Genes2021
Gα q signaling in primary sensory neurons shifts opioid analgesia to NMDA receptor–driven tolerance and hyperalgesia2025